Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

China · Delayed Price · Currency is CNY

13.45

-0.89 (-6.21%)

Oct 27, 2026, 3:04 PM CST

Market Cap	10.23B -9.7%
Revenue (ttm)	5.34B +3.7%
Net Income	262.14M +108.0%
EPS	0.34 +101.3%
Shares Out	760.85M
PE Ratio	39.56
Forward PE	29.89
Dividend	0.15 (1.09%)
Ex-Dividend Date	Sep 10, 2026

Volume	16,257,040
Open	13.28
Previous Close	14.34
Day's Range	13.28 - 14.47
52-Week Range	10.42 - 20.37
Beta	0.28
Analysts	Buy
Price Target	18.75 (+39.41%)
Earnings Date	Oct 30, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. The company offers technological research, including cell technology, complex preparation, injection, and OSD laboratory; instruments comprising cell therapy and nucleic acid drugs instruments, laboratory facilities, and table reactor; single use technology that include bioreactors, liquid distribution systems, sterile bags, process chromatography, membrane filtration syst... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1993

Employees 5,479

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300171

Full Company Profile

Financial Performance

In 2025, SHE:300171's revenue was 5.23 billion, an increase of 4.45% compared to the previous year's 5.01 billion. Earnings were 200.38 million, an increase of 3.24%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 300171 stock is "Buy." The 12-month stock price target is ¥18.75, which is an increase of 39.41% from the latest price.

Price Target

¥18.75

(39.41% upside)

Analyst Consensus: Buy

Stock Forecasts